p53 rodent Search Results


93
Cell Signaling Technology Inc rodent specific phosphospecific ser15 p53
Regulation of the DNA damage response by α4 protein expression in cardiomyocytes. H9c2 cardiomyocytes were transfected with either 50 nM non-targeting control (NTC) siRNA or 50 nM siRNA specific to rat α4 protein (siα4) for 1–4 days (n = 4) and the KD of α4 protein expression was confirmed by Western analysis using an antibody raised against human α4 ( a ). α4 protein expression was knocked down for 4 days and Western analysis (short and long exposures) was used to probe samples (n = 3) with an antibody specific to phosphorylated S / T QG motifs within ATM/ATR substrates. Arrows indicate substrates whose phosphorylation status (n = 3) was elevated in response to α4 KD ( b ). The expression and phosphorylation <t>(Ser15)</t> of <t>p53</t> were determined by Western analysis using rodent-specific antibodies raised against mouse <t>p53</t> <t>protein</t> in samples following 4 days of α4 KD, n = 5 ( c ). The expression of PARP was determined by Western analysis (short and long exposures) following 1–4 days of α4 KD, n = 3. Arrows indicate full length PARP (116 kDa) and cleaved fragments (89 kDa and 24 kDa) ( d ). All data represents data mean values ± SEM and statistical significance vs. non-targeting control (NTC) was determined by a one-tailed Student’s T-test. Expression of β-actin was used to confirm equal protein loading between samples.
Rodent Specific Phosphospecific Ser15 P53, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53+rodent/Phospho-p53+(Ser15)+Rabbit+mAb/pmc07973735-209-25-36
Average 93 stars, based on 1 article reviews
rodent specific phosphospecific ser15 p53 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc p53 rodent specific
Regulation of the DNA damage response by α4 protein expression in cardiomyocytes. H9c2 cardiomyocytes were transfected with either 50 nM non-targeting control (NTC) siRNA or 50 nM siRNA specific to rat α4 protein (siα4) for 1–4 days (n = 4) and the KD of α4 protein expression was confirmed by Western analysis using an antibody raised against human α4 ( a ). α4 protein expression was knocked down for 4 days and Western analysis (short and long exposures) was used to probe samples (n = 3) with an antibody specific to phosphorylated S / T QG motifs within ATM/ATR substrates. Arrows indicate substrates whose phosphorylation status (n = 3) was elevated in response to α4 KD ( b ). The expression and phosphorylation <t>(Ser15)</t> of <t>p53</t> were determined by Western analysis using rodent-specific antibodies raised against mouse <t>p53</t> <t>protein</t> in samples following 4 days of α4 KD, n = 5 ( c ). The expression of PARP was determined by Western analysis (short and long exposures) following 1–4 days of α4 KD, n = 3. Arrows indicate full length PARP (116 kDa) and cleaved fragments (89 kDa and 24 kDa) ( d ). All data represents data mean values ± SEM and statistical significance vs. non-targeting control (NTC) was determined by a one-tailed Student’s T-test. Expression of β-actin was used to confirm equal protein loading between samples.
P53 Rodent Specific, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53+rodent/p53+Rabbit+mAb/pmc06510239-487-40-57
Average 95 stars, based on 1 article reviews
p53 rodent specific - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti rodent p53
Regulation of the DNA damage response by α4 protein expression in cardiomyocytes. H9c2 cardiomyocytes were transfected with either 50 nM non-targeting control (NTC) siRNA or 50 nM siRNA specific to rat α4 protein (siα4) for 1–4 days (n = 4) and the KD of α4 protein expression was confirmed by Western analysis using an antibody raised against human α4 ( a ). α4 protein expression was knocked down for 4 days and Western analysis (short and long exposures) was used to probe samples (n = 3) with an antibody specific to phosphorylated S / T QG motifs within ATM/ATR substrates. Arrows indicate substrates whose phosphorylation status (n = 3) was elevated in response to α4 KD ( b ). The expression and phosphorylation <t>(Ser15)</t> of <t>p53</t> were determined by Western analysis using rodent-specific antibodies raised against mouse <t>p53</t> <t>protein</t> in samples following 4 days of α4 KD, n = 5 ( c ). The expression of PARP was determined by Western analysis (short and long exposures) following 1–4 days of α4 KD, n = 3. Arrows indicate full length PARP (116 kDa) and cleaved fragments (89 kDa and 24 kDa) ( d ). All data represents data mean values ± SEM and statistical significance vs. non-targeting control (NTC) was determined by a one-tailed Student’s T-test. Expression of β-actin was used to confirm equal protein loading between samples.
Anti Rodent P53, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53+rodent/p53+Antibody/pm10617580-47-9-37
Average 96 stars, based on 1 article reviews
anti rodent p53 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc rabbit anti p53
Regulation of the DNA damage response by α4 protein expression in cardiomyocytes. H9c2 cardiomyocytes were transfected with either 50 nM non-targeting control (NTC) siRNA or 50 nM siRNA specific to rat α4 protein (siα4) for 1–4 days (n = 4) and the KD of α4 protein expression was confirmed by Western analysis using an antibody raised against human α4 ( a ). α4 protein expression was knocked down for 4 days and Western analysis (short and long exposures) was used to probe samples (n = 3) with an antibody specific to phosphorylated S / T QG motifs within ATM/ATR substrates. Arrows indicate substrates whose phosphorylation status (n = 3) was elevated in response to α4 KD ( b ). The expression and phosphorylation <t>(Ser15)</t> of <t>p53</t> were determined by Western analysis using rodent-specific antibodies raised against mouse <t>p53</t> <t>protein</t> in samples following 4 days of α4 KD, n = 5 ( c ). The expression of PARP was determined by Western analysis (short and long exposures) following 1–4 days of α4 KD, n = 3. Arrows indicate full length PARP (116 kDa) and cleaved fragments (89 kDa and 24 kDa) ( d ). All data represents data mean values ± SEM and statistical significance vs. non-targeting control (NTC) was determined by a one-tailed Student’s T-test. Expression of β-actin was used to confirm equal protein loading between samples.
Rabbit Anti P53, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53+rodent/p53+Antibody/pmc07268994-113-12-17
Average 97 stars, based on 1 article reviews
rabbit anti p53 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology p53 rodent specific
(A) Immunoblot for <t>phospho-p53</t> (S18), total p53, and actin in MEF cells cultured in complete or glutamine-free medium for 18 h.
P53 Rodent Specific, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53+rodent/p-p53+Antibody/pmc06510239-541-40-33
Average 94 stars, based on 1 article reviews
p53 rodent specific - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology p53 rodent
Figure 6. Effects of L. draba extract on <t>p53-positive</t> cells in (A) kidney and liver tissues (DAB staining 400×, scale bar = 25 μm). (B) Quantitative results of immunohistochemical examination. Data are shown as mean ± SEM (n=6).
P53 Rodent, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p53+rodent/p53/10__4103_slash_apjtb__apjtb_518_24-130-6-17
Average 96 stars, based on 1 article reviews
p53 rodent - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Regulation of the DNA damage response by α4 protein expression in cardiomyocytes. H9c2 cardiomyocytes were transfected with either 50 nM non-targeting control (NTC) siRNA or 50 nM siRNA specific to rat α4 protein (siα4) for 1–4 days (n = 4) and the KD of α4 protein expression was confirmed by Western analysis using an antibody raised against human α4 ( a ). α4 protein expression was knocked down for 4 days and Western analysis (short and long exposures) was used to probe samples (n = 3) with an antibody specific to phosphorylated S / T QG motifs within ATM/ATR substrates. Arrows indicate substrates whose phosphorylation status (n = 3) was elevated in response to α4 KD ( b ). The expression and phosphorylation (Ser15) of p53 were determined by Western analysis using rodent-specific antibodies raised against mouse p53 protein in samples following 4 days of α4 KD, n = 5 ( c ). The expression of PARP was determined by Western analysis (short and long exposures) following 1–4 days of α4 KD, n = 3. Arrows indicate full length PARP (116 kDa) and cleaved fragments (89 kDa and 24 kDa) ( d ). All data represents data mean values ± SEM and statistical significance vs. non-targeting control (NTC) was determined by a one-tailed Student’s T-test. Expression of β-actin was used to confirm equal protein loading between samples.

Journal: Scientific Reports

Article Title: Regulation of cardiomyocyte DNA damage and cell death by the type 2A protein phosphatase regulatory protein alpha4

doi: 10.1038/s41598-021-85616-5

Figure Lengend Snippet: Regulation of the DNA damage response by α4 protein expression in cardiomyocytes. H9c2 cardiomyocytes were transfected with either 50 nM non-targeting control (NTC) siRNA or 50 nM siRNA specific to rat α4 protein (siα4) for 1–4 days (n = 4) and the KD of α4 protein expression was confirmed by Western analysis using an antibody raised against human α4 ( a ). α4 protein expression was knocked down for 4 days and Western analysis (short and long exposures) was used to probe samples (n = 3) with an antibody specific to phosphorylated S / T QG motifs within ATM/ATR substrates. Arrows indicate substrates whose phosphorylation status (n = 3) was elevated in response to α4 KD ( b ). The expression and phosphorylation (Ser15) of p53 were determined by Western analysis using rodent-specific antibodies raised against mouse p53 protein in samples following 4 days of α4 KD, n = 5 ( c ). The expression of PARP was determined by Western analysis (short and long exposures) following 1–4 days of α4 KD, n = 3. Arrows indicate full length PARP (116 kDa) and cleaved fragments (89 kDa and 24 kDa) ( d ). All data represents data mean values ± SEM and statistical significance vs. non-targeting control (NTC) was determined by a one-tailed Student’s T-test. Expression of β-actin was used to confirm equal protein loading between samples.

Article Snippet: Antibodies to detect Bax (#2772), Bcl-xL (#2762), phosphospecific ATM/ATR substrate (#6966), IGBP1 (α4) (#5699), PARP (#9542), phosphospecific (Ser139) H2AX (#9718), H2AX (#2595), rodent-specific p53 (#32532), rodent-specific phosphospecific (Ser15) p53 (#12571) and V5-tag (#13202) were obtained from Cell Signaling Technology (USA).

Techniques: Expressing, Transfection, Control, Western Blot, Phospho-proteomics, One-tailed Test

(A) Immunoblot for phospho-p53 (S18), total p53, and actin in MEF cells cultured in complete or glutamine-free medium for 18 h.

Journal: Cell reports

Article Title: p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake

doi: 10.1016/j.celrep.2019.02.037

Figure Lengend Snippet: (A) Immunoblot for phospho-p53 (S18), total p53, and actin in MEF cells cultured in complete or glutamine-free medium for 18 h.

Article Snippet: Immunoblotting was performed with the following antibodies: p53, rodent (CM5) was purchased from VECTOR Laboratories, Burlingame, CA, USA; p53, human (DO-1, SC126) and CAT-3, mouse (T-14, sc161433) were purchased from Santa Cruz Biotechnology, Santa Cruz, CA, USA; phospho-p53 (Ser15, #9284), p53 rodent specific (D2H90, #32532), phospho-p70S6K (Thr389, #9234), p70S6K (#2708) and ATF4 (D4B8, #11815) were purchased from Cell Signaling Technology, Danvers, MA, USA, and beta actin (A1978) from Sigma-Aldrich, St. Louis, MO, USA.

Techniques: Western Blot, Cell Culture

(A) Relative arginine levels of MEF WT and p53−/− cells cultured in complete or glutamine-free medium for 6 h.

Journal: Cell reports

Article Title: p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake

doi: 10.1016/j.celrep.2019.02.037

Figure Lengend Snippet: (A) Relative arginine levels of MEF WT and p53−/− cells cultured in complete or glutamine-free medium for 6 h.

Article Snippet: Immunoblotting was performed with the following antibodies: p53, rodent (CM5) was purchased from VECTOR Laboratories, Burlingame, CA, USA; p53, human (DO-1, SC126) and CAT-3, mouse (T-14, sc161433) were purchased from Santa Cruz Biotechnology, Santa Cruz, CA, USA; phospho-p53 (Ser15, #9284), p53 rodent specific (D2H90, #32532), phospho-p70S6K (Thr389, #9234), p70S6K (#2708) and ATF4 (D4B8, #11815) were purchased from Cell Signaling Technology, Danvers, MA, USA, and beta actin (A1978) from Sigma-Aldrich, St. Louis, MO, USA.

Techniques: Cell Culture

(A) Immunoblot of phospho-S6K (T389), total S6K, total p53, and actin in SaOs-2 cells cultured in the absence or presence of doxycycline for 24 h and then separated into complete and glutamine-free medium for 3-h increments.

Journal: Cell reports

Article Title: p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake

doi: 10.1016/j.celrep.2019.02.037

Figure Lengend Snippet: (A) Immunoblot of phospho-S6K (T389), total S6K, total p53, and actin in SaOs-2 cells cultured in the absence or presence of doxycycline for 24 h and then separated into complete and glutamine-free medium for 3-h increments.

Article Snippet: Immunoblotting was performed with the following antibodies: p53, rodent (CM5) was purchased from VECTOR Laboratories, Burlingame, CA, USA; p53, human (DO-1, SC126) and CAT-3, mouse (T-14, sc161433) were purchased from Santa Cruz Biotechnology, Santa Cruz, CA, USA; phospho-p53 (Ser15, #9284), p53 rodent specific (D2H90, #32532), phospho-p70S6K (Thr389, #9234), p70S6K (#2708) and ATF4 (D4B8, #11815) were purchased from Cell Signaling Technology, Danvers, MA, USA, and beta actin (A1978) from Sigma-Aldrich, St. Louis, MO, USA.

Techniques: Western Blot, Cell Culture

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake

doi: 10.1016/j.celrep.2019.02.037

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Immunoblotting was performed with the following antibodies: p53, rodent (CM5) was purchased from VECTOR Laboratories, Burlingame, CA, USA; p53, human (DO-1, SC126) and CAT-3, mouse (T-14, sc161433) were purchased from Santa Cruz Biotechnology, Santa Cruz, CA, USA; phospho-p53 (Ser15, #9284), p53 rodent specific (D2H90, #32532), phospho-p70S6K (Thr389, #9234), p70S6K (#2708) and ATF4 (D4B8, #11815) were purchased from Cell Signaling Technology, Danvers, MA, USA, and beta actin (A1978) from Sigma-Aldrich, St. Louis, MO, USA.

Techniques: Plasmid Preparation, Control, Virus, Recombinant, Protease Inhibitor, cDNA Synthesis, SYBR Green Assay, Transformation Assay, Generated, shRNA

Figure 6. Effects of L. draba extract on p53-positive cells in (A) kidney and liver tissues (DAB staining 400×, scale bar = 25 μm). (B) Quantitative results of immunohistochemical examination. Data are shown as mean ± SEM (n=6).

Journal: Asian Pacific Journal of Tropical Biomedicine

Article Title: Hepatorenoprotective effects of Lepidium draba L. extracts against cyclophosphamide-induced oxidative injuries in rats via reducing apoptosis and inflammation

doi: 10.4103/apjtb.apjtb_518_24

Figure Lengend Snippet: Figure 6. Effects of L. draba extract on p53-positive cells in (A) kidney and liver tissues (DAB staining 400×, scale bar = 25 μm). (B) Quantitative results of immunohistochemical examination. Data are shown as mean ± SEM (n=6).

Article Snippet: The slides were then incubated in p53 rodent-specific monoclonal antibody (Cat. no. sc-98, Pab 1801, dilution 1꞉200, Santa Cruz Biotechnology) for 45 min at room temperature, then incubated for 5 min in 5% bovine serum albumin to block unbound antibodies, and finally in chromogen (3, 3’-diaminobenzidine) for 30 min at 37 曟. Counterstaining of the slides was performed with hematoxylin and 50 fields of view were randomly evaluated with a light microscope (Olympus CH3, Japan) attached to the camera (Moticam Technologies, Japan), and the p53 positive cells/total cells × 100 was calculated at 400× magnification and reported as mean (%) ± SEM[23].

Techniques: Staining, Immunohistochemical staining